Privi Speciality Chemicals working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
223.71×223.71×233.52×263.75×268.85×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
65.50×65.50×64.42×66.98×63.63×
128.82×128.82×110.45×104.22×111.64×
160.39×160.39×187.49×226.51×220.84×
5.43×5.09×8.08×7.13×15.91×
0.86×0.86×0.82×0.74×0.70×
1.74×1.74×1.52×3.71×2.29×
0.85×0.85×0.62×1.09×0.26×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PRIVISCL₹3,296.30

Privi Speciality Chemicals Ltd.

· Chemicals
₹ CrorePeersAARTIINDRAINRALLISRCFNFLREFEXNEOGENLXCHEMMcap ₹12,876 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)268.85263.75233.52223.71223.71
Receivable Days (DSO)63.6366.9864.4265.5065.50
Payable Days (DPO)111.64104.22110.45128.82128.82
Cash Conversion Cycle (days)220.84226.51187.49160.39160.39
Working Capital Turnover15.917.138.085.095.43
Asset Turnover0.700.740.820.860.86
Cash Conversion (CFO/Net Income)2.293.711.521.741.74
CFO/EBITDA0.261.090.620.850.85
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.